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Background/aim: The objective of this study is to determine the clinical features of unilateral multicystic dysplastic kidney (MCDK)
patients.
Materials and methods: The demographic, clinical, laboratory, and radiologic features of MCDK patients at Diyarbakır Children’s
Hospital and Diyarbakır Gazi Yaşargil Training and Research Hospital between January 2008-June 2019 were retrospectively evaluated.
Results: A total of 111 [59 (53.2%) male and 52(46.8%) female] patients with MCDK were followed for a mean period of 41.89 ± 32.03
months. MCDK was located on the left and right sides in 46 (41.4%) and 65 (58.6%) of the children, respectively (p > 0.05). A total of
87 (78.4%) patients had antenatal diagnosis. The mean age at diagnosis was 13.7 ± 34.2 months. Of the 49 voiding cystourethrogram
(VCUG)-performed patients, vesicoureteral reflux was detected in 11 patients (22.4%). Other associated urological anomalies in the
patients were detected in 12 (10.8%) patients. On Tc-99m dimercaptosuccinic acid (DMSA) scintigraphy which was performed in all
patients showed scarring in four children. Eight patients had history of UTI (7.2%). Renal failure, hypertension, and proteinuria were
diagnosed in three children (2.7%). Sixty-nine (62%) patients developed compensatory hypertrophy.
Conclusion: All cases should be followed up closely and VCUG should be reserved for patients with recurrent UTI and other urological
problems indicated by ultrasonography and abnormal DMSA scan results.
Key words: Multicystic dysplastic kidney, children, vesicoureteral reflux, contralateral anomalies

1. Introduction
Multicystic dysplastic kidney (MCDK) is a developmental
anomaly of the kidney and it is the most common cause of
cystic renal disease in children [1]. It is characterized by the
enlargement of the kidney, multiple, noncommunicating
cysts of varying size, no functioning kidney parenchyma,
and atresia or hypoplasia of the ureter [2]. The incidence
is 1 in 1000–4300 live births [3]. Although the use of
antenatal and postnatal ultrasonography (US) has become
wide spread in the past 20 years, MCDK may still be
asymptomatic and may not be detected until adulthood
[4]. The condition occurs more commonly in males than
females (2.4:1) and the left kidney is more affected than the
right kidney [5]. MCDK is mostly an isolated condition;
however, the contralateral urinary tract could be affected
by other abnormalities such as vesicoureteral reflux
(VUR), ureteropelvic junction obstruction (UPJO) and
ureterovesical obstruction (UVJO) [6,7].

There are three major issues in patients with unilateral
MCDK and the fate of the contralateral functioning
kidney [8]. Firstly, MCDK may undergo complete or
partial involution within time [9]. Secondly, although
it is presumably thought to have increased risk for the
incidence of Wilms tumor in the past, it is not widely
accepted today [10]. And thirdly, the risk of hypertension
in MCDK has been found to be high but no higher than in
the general pediatric population [8].
Although the US is the first-line and basic imaging
technique for the follow-up period of MCDK, renal
scintigraphy provides additional information such
as the function of renal cortical tissue in MCDK, the
involvement of contralateral kidney, and/or presence of
any scar and/or hypodysplasia. Therefore, it is suggested
to perform the Tc-99m dimercaptosuccinic acid (DMSA)
scintigraphy at least once at a follow-up period in MCDK
patients [10–13].
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The management of MCDK has changed greatly
over time. Previously, nephrectomy was performed to
avoid infection, pain, hypertension, and malignancy [14].
Recently, management is primarily conservative due to
favorable outcome of patients [15].
Here we present 11-year of retrospective data from
111 MCDK patients. We primarily wanted to describe the
clinical, laboratory findings and secondarily, we wanted to
discuss whether routine VCUG should be performed with
no history of urinary tract infections and no pathological
findings on US and DMSA scintigraphy imaging.
2. Materials and methods
2.1. Study design
We retrospectively reviewed the medical records of 139
patients with MCDK whom were followed at Diyarbakır
Children’s Hospital and Diyarbakır Gazi Yaşargil Training
and Research Hospital from January 2008 to June 2019.
As we excluded 28 patients who had incomplete medical
records and irregular follow-up or whose follow-up
duration time was less than 1 year, who had other genetic
and chromosome abnormalities, spinal cord diseases, or
anal atresia. A total of 111 patients were enrolled in this
study. We evaluated clinical parameters including sex, age at
diagnosis, parental consanguinity, family history for renal
diseases, side of the affected kidney, renal function tests
(serum urea and creatinine levels), estimated glomerular
filtration rate (e-GFR) with Schwartz Formula [16], history
of urinary tract infection (UTI), hypertension, malignancy,
additional urological anomalies, congenital heart diseases,
previous operations, nephrectomy indications for those
that underwent nephrectomy because of MCDK and
finally follow-up time.
2.2. Diagnosis and follow-up
The diagnosis of MCDK was made according to
ultrasonography. The diagnosis was based on the following
established ultrasound criteria: (1) multiple cysts of varying
size, (2) absence of normal renal sinus echoes, and (3)
absence of normal renal parenchyma [17]. The absence of
Tc-99m dimercaptosuccinic acid (DMSA) scintigraphy was
used to confirm the diagnosis of MCDK. Compensatory
hypertrophy of the contralateral kidney was defined as
renal length >2 standard deviations (SD) of the mean value
of normal kidneys according to age [18].
Patients with neither UTI nor abnormality of
contralateral kidney were assessed with urinalysis, urinary
culture, and control US of urinary system every 3 months
until 1 year of age. The same evaluation was performed
every 6 months between 1 and 2 years of age and annually
or twice per year thereafter. Those with a history of UTI
and abnormality of contralateral kidney were evaluated
according to the condition of the patients. The urea and
creatinine levels were checked in the first week of life for
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the patients who were diagnosed antenatally and they were
checked out once per year or year after. Hypertension is
defined as each systolic and/or diastolic blood pressure
≥95th percentile measured on three or more separate
occasions for age, sex, and height [19].
2.3. Performing voiding cystourethrogram (VCUG) and
evaluation of urinary tract infection
VCUG was performed in the patients who had
US abnormalities in the contralateral kidney (e.g.,
hydronephrosis or hydroureteronephrosis, increased
echogenicity in the renal parenchyma), scan abnormality
on the unaffected kidney and/or UTI. Vesicoureteral
reflux on VCUG was graded according to the international
classification for grading of VUR [20]. Antibiotic
prophylaxis was given to patients with high grades of VUR
and continued till resolution or decline of VUR grade or
completing of toilet training. If patients had suspected
of UTI, with symptoms such as fever, oral intolerance in
infancy, dysuria, vomiting, abdominal pain, and frequency,
urine samples were collected. Urinary tract infection was
defined as the presence of pyuria (≥5 white blood cells per
high-power field), and/or positive leukocyte esterase test
or nitrite, and a result of a positive urine culture test. Any
growth of a single bacterium from a suprapubic bladder
aspiration, or growth of a single microorganism from
≥105 colony-forming units/mL from a midstream cleanvoid urine specimen in toilet-trained children, or ≥5 ×
104 colony-forming units/mL collected from transurethral
catheterized specimen was considered significant.
2.4. Evaluation of proteinuria and renal functions
Proteinuria was tested with a urine dipstick method at
every outpatient visit, if proteinuria was detected for more
than two occasions with the dipstick method, further
evaluation was made with spot urine protein/creatinine
ratio or 24-h urine collection. Pathological proteinuria
was defined as >0.2 mg/mg or >4 mg/m2/h, respectively
[21]. Blood urea and creatinine levels and eGFR rates
were used to determine renal functions. Chronic kidney
disease (CKD) was defined as eGFR <60 mL/min/1.73 m2
for more than 3 months; patients with CKD were further
categorized into five groups according to their eGFR and
KDOQI guideline [22].
2.5. Statistical analysis
SPSS v. 22.0 software (IBM Corp., Armonk, NY, USA)
was used for data analysis. The Kolmogorov–Smirnov
test was used for evaluating data distribution. Descriptive
statistics were presented as number of observations and
percentage (%). Parametric data was expressed as mean
± standard deviation (SD) and nonparametric data as
median (minimum–maximum). Student’t t-test was used
to compare the normally distributed and the Mann–
Whitney U test to compare non-normally distributed
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data. Differences in proportions were assessed using the
chi-squared test. The results with p < 0.05 were considered
statistically significant.
3. Results
The clinical characteristics of 111 patients with MCDK in
the study are summarized in Table 1. Of the patients, 59
(53.2%) were male and 52 (46.8%) were female. The mean
age at diagnosis was 13.7 ± 34.2 months (range: 1–192
months). A total of 87 (78.4%) patients had antenatal
diagnosis. The remaining 24 (21.6%) patients were
diagnosed incidentally because of nonspecific abdominal
pain and/or UTI. Unilateral MCDK was on the right side
in 65 patients (58.6%) and on the left side in 46 patients
(41.4%). Follow-up duration was 12–132 months (mean:
41.89 ± 32.03 months) and mean age at last control visits
was 4.58 ± 3.89 years (1–17 years). In our study, parental
consanguinity and family history of congenital anomalies
of the kidney and urinary tract (CAKUT) was detected
in 64.9% and 11.7% of the patients, respectively. In these
patients, families’ congenital anomalies of kidney and
urinary tract anomalies such as renal agenesis, MCDK,
renal hypoplasia, and horse kidney were identified.
Mean serum creatinine level was 0.51 ± 0.23 mg/dL
(range: 0.1–0.7 mg/dL) and serum urea level was 23.9 ±
16.2 mg/dL (range: 8–140 mg/dL). The mean eGFR was
153.23 ± 27.52 mL/min/1.73 m2 (range: 23–204 mL/
min/1.73m2); unfortunately, three of the patients had renal
failure (stage III CKD). Hypertension and proteinuria was
diagnosed in three children (2.7%). These patients were
also diagnosed with stage III chronic kidney disease.
A total of 49 VCUGs were performed (44.1%) and
VUR was detected only in 11 patients (22.4%). In most of
the patients, UTI and/or confirmed ureter dilatation was
the key point for performing VCUG. Contralateral VUR

was detected in 9 patients (18.2%) (Grade I, 2 patients;
Grade II, 2 patients; Grade IV, 3 patients; and Grade V, 2
patients) and two patients had bilateral VUR (4.2%) (Table
2). DMSA was performed in all patients. All of them
showed no parenchymal function at the affected site. Four
children had scarring on DMSA imaging. Three of them
had stage III chronic kidney disease. One of these patients
had a history of stage I VUR on the affected side of kidney
and stage V VUR on the unaffected site, and a history of
performing surgical correction and ureteroneocystostomy
operation for the unaffected kidney. The other two
patients did not have VUR but had hypoplasic and/or
dysplasic kidney with neither extrarenal nor chromosomal
abnormality. The other patient was a 10-year-old girl who
had a history of UTI but had not been evaluated by a
pediatric nephrologist. VCUG was performed but VUR
was not detected; unfortunately, DMSA revealed scar in the
contralateral kidney. There was no statistically significant
relationship between renal scar and reflux in our patients
(p > 0.999, Fisher’s exact test). Similarly, there was no
statistically significant relationship between patients with
vesicoureteral reflux and those without vesicoureteral
reflux in terms of sex, age at diagnosis, affected side of
kidney, follow-up duration, hypertension, proteinuria,
urea, creatinine level, and eGFR (p = 0.732, Fisher’s exact
test; p = 0.859, Mann–Whitney U; p > 0.999, Fisher’s exact
test; p = 0.02, Student’s t-test; p > 0.999, Fisher’s exact test;
p > 0.999, Fisher’s exact test; p = 0.764, Mann–Whitney U;
p = 0.29, Mann–Whitney U; p = 0.69, Mann–Whitney U).
Of the 111 patients, 4 children had undergone
nephrectomy in other centers. In our clinic, none of the
remaining patients underwent surgery in the follow-up
duration. We were not able to evaluate the involution rates
and the reason of nephrectomy because of incomplete
data. On the other hand, compensatory hypertrophy in

Table 1. Characteristics of children with unilateral multicystic dysplastic kidney.
Feature

Number

Rate (%)

Sex
Female/male

52/59

46.8/53.2

Side of multicystic dysplastic kidney
Right/left

65/46

58.6/51.4

Parental consanguinity

72

64.9

Prenatal diagnosis

87

78.4

Family history of renal disease

13

11.7

Decreased renal function

3

2.7

Congenital heart disease

4

3.6

Hypertension

3

2.7

Proteinuria

3

2.7

History of urinary tract infection

8

7.2
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Table 2. Contralateral vesicoureteral reflux and other urinary
system anomalies accompanying to multicystic dysplastic kidney.
Patient number

Rate (%)

Contralateral VUR

9

18.2

Hypdysplasia/dysplasia

2

1.8

UPJO

5

4.5

UVJO

1

0.9

Ipsilateral ureteroceles

3

2.7

Undescended testis

2

1.8

Hypospadias

1

0.9

VUR: Vesicoureteral reflux, UPJO: Ureteropelvic junction
obstruction, UVJO: Ureterovesical junction obstruction.

the contralateral kidney was detected in 69 (62%) of the
patients. No malignant transformation was observed in
patients.
The other associated urologic anomalies are given
in Table 2. While surgical procedure was performed in
patients with hypospadias and undescended testicles,
UPJO and UVJO patients did not require any operation.
Congenital heart disease was the most common extrarenal
finding. Of the 4 patients (3.6%), 3 had atrial septal defect
and 1 had ventricular septal defect. One patient had mental
retardation and epilepsy due to hypoxic birth history.
4. Discussion
The frequency of diagnosis of MCDK has increased in
recent years because of the widespread use of antenatal
and postnatal ultrasound [23,24]. MCDK is accepted to
be a benign condition but early identification of associated
abnormalities and appropriate management of these
patients are crucial in children due to having solitary
kidney [25–27].
In the present series, unilateral MCDK was seen
more commonly in males than in females, and mostly
the left kidney was more affected than the right [5]. The
study includes 111 children with a male-to-female ratio
of 1.13. Our study revealed that males are more affected
than females but right side involvement was higher apart
from the literature. In the literature, prenatal diagnosis rate
varies related to local features of the institutions. Schreuder
et al. reported the prenatal diagnosis rate as 90.8% in their
metaanalysis and Moralıoğlu et al. reported the prenatal
diagnosis rate as 94.1% of the patients with MCDK
[25,26]. Despite these two high rates, Kara et al. reported
the diagnosis rate as 50% [11]. In our opinion, the rate
may be related with the socioeconomic status of families
and regular antenatal follow-up. Our study revealed that
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prenatal diagnosis rate was 78.4%. In our study, we detected
high rates of consanguinity (64.9%), so this situation seems
to relate with common consanguineous marriage in our
country especially in our region. We found that 11.7% of
our patients had CAKUT (renal agenesis, renal hypoplasia,
MCDK, horseshoe kidney) in their family members. In a
study, 94 family members of MCDK patients for CAKUT
were screened, and 3 MCDK and one renal agenesis were
detected [28]. Thus, the authors advocated that no formal
familial screening recommended and MCDK defined
as a sporadic condition. We did not routinely screen our
patients’ family members either.
Renal ultrasonography is recommended as a
preliminary diagnostic imaging study. According to the
DMSA results of a seven-cohort study, among 27 of the
347 patients (7.7%), activity range on DMSA was 1%–18%
at the affected site [25]. In the present study, DMSA scan
showed no parenchymal function at the affected site in
all patients and four children had scar at the unaffected
kidney.
Prognosis of patients with MCDK is generally related to
the function of the contralateral kidney, and abnormalities
of contralateral urinary tract and bladder. Contralateral
urological abnormalities were detected in 16 (14.4%)
patients in our series. Previous series reported contralateral
anomalies in 14.7%–20% of the patients [9,25]. Our study
showed quite similar results with these reports. The rate of
VUR of the contralateral kidney had been noted between
4.5% and 43.0% in previous studies [26,29,30]. It was
18.2% in our study. Some authors revealed that the rate
of the high-grade VUR (grade III, IV, V) in the affected
contralateral kidney varied from 26.0% to 50.0% and
only a few patients required antireflux surgery [9,25,29].
In our study, only five patients had high-grade reflux to
the contralateral kidney and through it only two patients
required antireflux surgery. Although two of these patients
had a renal scar in the contralateral kidney, the renal scar
was already present in the first scintigraphies. In the light
of these results, we also thought that routine VCUG was
unnecessary like these authors pointed out [29,31]. Since
VCUG is an invasive process, it is stressful for both patients
and their families, along with exposing radiation, urethral
trauma, and iatrogenic UTI [32]. Moreover, a spontaneous
resolution is possible, especially in low-grade VUR [33].
Blachman-Braun et al. evaluated 156 MCDK patients; 38
of them had abnormal US findings in the contralateral
kidney, and when a VCUG was performed, they found 25
patients with VUR; however; only two of them had severe
VUR. They showed a statistical correlation between the
severity of VUR and abnormal US findings [34]. Therefore,
they concluded that patients with abnormal contralateral
US findings would benefit the most from VCUG. However,
despite the evidence supporting an association between
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UTI and VUR, there is no convincing evidence that
either UTI or VUR contributes to the progression of CKD
to end-stage kidney disease (ESKD); in these patients,
the main cause of CKD/ESKD could be the presence of
the hypoplastic kidney itself rather than the VUR [35].
Although US findings could predict patients with severe
VUR, evaluation of patients for UTI with a DMSA scan
would provide a more effective estimation.
There are some other urological problems including
CAKUT that could be detected in MCDK. Contralateral
UPJO rates vary between 1.1% and 13% in previous
studies [25,26]. Our study also indicated that UPJO rates
were 4.5%, and none of these patients required surgery.
Ipsilateral urological abnormalities were obtained in three
of our patients (2.7%). All were ipsilateral nonsymptomatic
ureteroceles. In a report, the authors detected ipsilateral
ureteroceles in six patients (4.9%) [7]. Thus, our coexisting
CAKUT spectrum anomalies are comparable with the
literature.
Multicystic dysplastic kidney is generally asymptomatic.
Abdominal or flank pain and respiratory distress are
uncommon symptoms because of the pressure effect
of the abnormal kidney [11]. In our cohort, all patients
were asymptomatic. The complications of MCDK include
hypertension, UTI, and renal malignancy. One of the
important complications of MCDK is UTI and it has been
reported in 5%–34.7% of the patients [25,29]. In a study by
Calaway et al., no statistically significant relationship was
found between UTI and renal scar, with or without VUR
[10]. We also reached similar results in our study.
The rate of hypertension in MCDK is not welldefined and has wide published rates from 0.6% to 17.7%
[14]. A nonfunctional bloodless kidney could be the
cause of hypertension in infancy and early childhood.
Indeed, presence of any accompanying congenital
urinary abnormality such as UPJO, renal dysplasia,
and development of a pyelonephritic scar secondary to
VUR and the effects of hyperfiltration over time in the
contralateral kidney has been considered a potential cause
of hypertension [11]. In the present study, hypertension
was diagnosed in three patients (2.7%). One of the patients
had high-grade reflux to contralateral kidney with renal
scarring. The other two patients had contralateral renal
dysplasia. Both of these patients were considered to
have stage III CKD, and antihypertensive treatment was
initiated.
Contralateral kidney usually undergoes compensatory
hypertrophy. The rate of compensatory hypertrophy of
the contralateral kidney varies from 16.6% to 89.8%.
[7,26,29]. It is considered that if there is no hypertrophy,

the practitioner should be suspicious of the contralateral
kidney having an abnormality [9]. We detected
compensatory hypertrophy in 69 patients (62%); therefore,
except three CKD patients, the rest of the study group had
normal kidney functions and dimensions. Our result was
62% (69 patients) and was in line with the literature. It may
be possible to observe compensatory hypertrophy during
longer follow-up. It is well known that kidneys with MCDK
involute within time, but there are variable data about the
time of involution in the literature [3]. Unfortunately,
we were not able to give our involution data because of
missing files.
It is already known that MCDK often undergoes
involution and malignant transformation has been
reported very rare and strict blood pressure measurement
and US examination for hypertension are recommended
[36–38]. During the follow-up period of our patients, no
patient was suspected of malignant transformation. In our
follow-up, nephrectomy has not been performed in any
case, while four patients underwent nephrectomy in other
centers.
Our study is with limitations such as retrospective
methodology, a retrospective evaluation of the frequency
and characteristics of the UTI, no records of prophylactic
antibiotics, and ultrasonographies performed by different
radiologists.
5. Conclusion
Multicystic dysplastic kidney is the most common
cause of renal cystic disease with a good prognosis in
childhood. We advocate that VCUG should be reserved
for patients with recurrent UTI and other urological
problems indicated by US and abnormal DMSA scan
results. These decrease unnecessary VSUG imaging.
Moreover, pediatric nephrologists should be careful about
that hypertension, renal dysfunction, proteinuria, and
malignant transformation could develop in a small part of
the MCDK patients.
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